{
    "links": "https://www.ycombinator.com/companies/tradewind-bioscience",
    "name": "Tradewind BioScience",
    "headline": "Tradewind translates scientific insight into innovative ways of\u00e2\u0080\u00a6",
    "batch": "W18",
    "description": "Our lead candidate is a multifaceted attack antibody for ovarian cancer. Our approach enables targeting primary cancer cells directly, alongside enabling the immune system's natural anti-cancer function, all with one therapeutic antibody.",
    "activity_status": "Active",
    "website": "https://www.tradewindbio.com",
    "founded_date": 2017.0,
    "team_size": 2.0,
    "location": "San Francisco",
    "group_partner": null,
    "group_partner_yc": null,
    "company_linkedin": null,
    "company_twitter": null,
    "tags": "location:san-francisco-bay-area",
    "founders": [
        {
            "name": "Thaddeus Allen, Founder/CEO",
            "description": "As a full-time founder at Tradewind, my focus is on translating novel science into viable and novel therapeutic approaches and relating the value of our mission. This calls on skills and knowledge developed through 25 years of cancer research experience and more recent experience in business oriented rolls.\nSkills/Experience\n- PhD level cancer biologist\n- Management of a research team\n- Patent portfolio management and IP agreements\n- Scientific data analysis and interpretation",
            "linkedin": "https://www.linkedin.com/in/thaddeus-allen-1a80466/"
        }
    ],
    "status": true,
    "generated_description": "### Tradewind BioScience: Pioneering Cancer Treatment\n\nTradewind BioScience, founded in 2017 and part of Y Combinator\u2019s Batch W18, is making waves in cancer research from its base in San Francisco. With a lean team of just two, their laser-focused mission is to transform scientific insights into groundbreaking therapeutics aimed at tackling some of the most aggressive cancers, particularly ovarian cancer.\n\n#### The Mission\nTradewind\u2019s core mission is straightforward yet ambitious: to develop innovative drugs that effectively attack formidable human cancers. They aim not just for incremental improvements but transformative medicines that can significantly enhance patient outcomes. The company emphasizes a science-driven approach to drug development, leveraging deep expertise and proprietary knowledge to craft solutions that go beyond conventional treatments.\n\n#### Therapeutics and Diagnostics\nAt the heart of Tradewind\u2019s offerings is a multifaceted antibody designed to target ovarian cancer. This innovative approach allows for a dual-action mechanism\u2014directly attacking cancerous cells while also activating the immune system\u2019s natural defenses against tumors. More than just a therapeutic endeavor, Tradewind incorporates companion diagnostics into their strategy, ensuring they identify the right patient populations who stand to benefit the most from their treatments. By focusing on biomarker identification, they enhance the precision of their therapies, aligning treatment with patient needs.\n\n#### Company Overview\n- **Founded**: 2017\n- **Location**: San Francisco, CA\n- **Team**: 2 Employees\n- **Website**: [tradewindbio.com](https://www.tradewindbio.com)\n\nTradewind BioScience embodies a fresh approach to the complex challenge of cancer treatment. Their dual focus on drug development and diagnostics not only showcases innovation but also underscores a commitment to enhancing patient lives through science. Keep an eye on this company as they navigate the intricate landscape of biomedicine with a dedication to making a real difference.",
    "logo": "https://bookface-images.s3.us-west-2.amazonaws.com/logos/5b57d943fae32de8ff1cb480280141352b960eda.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=ASIAQC4NIECAKBB576US%2F20250221%2Fus-west-2%2Fs3%2Faws4_request&X-Amz-Date=20250221T192024Z&X-Amz-Expires=3600&X-Amz-Security-Token=IQoJb3JpZ2luX2VjELP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJHMEUCIFRjVxB%2FHxIJHUHkMazoRi02jYmaJVJGr3K7C9j9jiflAiEA6iszI4%2Fpn8hDzk7aMP6LlnqynbPgCG20CpdZqslTFdsq7gMI3P%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FARAAGgwwMDYyMDE4MTEwNzIiDNVC6v4lNMvTlUOjTyrCA7R4NjcD6pWk9Gjux5NdrMhwU67pNo%2F0JVDzkHcTjBsajnWXpXoyD3m%2FssX0rwYmnUDJB9VTgD%2FW2M8cWxeD93WFxLjs25juzzGj1%2BC1Ky9E0oNPwn5jGw%2BjokWylkxcouU18mjUtP8juH4uF9Xfmm%2FMAgvOPsNSAaYBQ%2BdA5Vwom66MCzynAPEJs6Nqxd5FqtgiiWFRhT5L9g%2FvfLTKqpdIg0XPF6s95lLCtwWDHST72Bn9JVH2zZmqjTgO2sao7Rg4M%2BPIRazg8JhbPoWk6xsB2yfG1f%2Bs8AFVxihyUnQj6TUnhrhezs7WYsaTfaaAoTIzhEsLwJDqBQDSptmSlUj%2BQ3KWwrXpJIm0b1uOmaylnrEpn5obECdRc%2FzdEfNt6DNEE5cbUhQo8Gjfd6MWfyV7JHtX7DwsLMssQPKNZ6qWJq2gP1fVHFkz5K0F%2F73p54AKB5gCkyOeRPJHmAzYMdfZpMF%2B8hE4eZU6k7m1EqPLEW2F9HVvcqPFp8T%2BZgbbDLBVWICSdX%2FfJ%2BniwyC72aHLaqjCxHLvJ6WyAawaepaDD9csEvz4DYD9lpHx9hJXqrFDyrT1vAaaBwuoXgulZ6gNmjCmiuO9BjqlATnnhPFnQUT7QmhXwrAFbGCqdgkRFIVCdDrNmasZJtz86frmIpB%2BlwZjavL0FMq46mN9RKFTuRNdMnOtOh1adMI%2BkC%2F%2Bs3m8pwR56JxErG%2B8nIBe7efeu5WiUZbGCsp85oXBCGY%2FoP1uWrJo843L0LVdmjtyXaDurxXSgzfeZo2RDONME7LNkPzuGzA19XefIc9OvA1QFcZr3VIdZe%2BLywfFgDpgwA%3D%3D&X-Amz-SignedHeaders=host&X-Amz-Signature=bb6fe8c8ebd5e8efc832d54fcf18638494e6d60bb48a43c8fdadffbcd76b6b69",
    "social_links": [
        "https://twitter.com/tradewindbio",
        "https://www.crunchbase.com/organization/tradewind-bioscience"
    ],
    "logo_path": "data/logos\\Tradewind_BioScience_logo.png"
}